SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
可乐不加冰
Lv1
80 积分
2022-04-06 加入
最近求助
最近应助
互助留言
Translational PK/PD framework for antibody-drug conjugates to inform drug discovery and development
3天前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
2个月前
已完结
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer
2个月前
已完结
Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis
5个月前
已完结
A fat-blocking drug could help to fight metastatic cancer
7个月前
已关闭
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
9个月前
已完结
Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics
1年前
已完结
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
1年前
已完结
CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer
1年前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
1年前
已完结
没有进行任何应助
已找到【积分已退回】
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论